TABLE 3.
Resistance by demographic characteristic for subjects from whom S. pneumoniae was isolated during the 2005-2006 respiratory season
| Patient category | No. of isolates tested | MIC90a (%) of isolates resistant to:
|
||||||
|---|---|---|---|---|---|---|---|---|
| Faropenemb | Cefdinir | Amoxicillin-clavulanate | Penicillin | Azithromycin | SXT | Levofloxacin | ||
| Age, yr | ||||||||
| <2 | 208 | 1 | >8 (33.2) | 8 (17.3) | 4 (30.8) | >16 (50.5) | 8 (42.8) | 1 (0) |
| 3-5 | 99 | 1 | >8 (23.2) | 8 (12.1) | 4 (21.2) | >16 (42.4) | >8 (30.3) | 1 (0) |
| 6-14 | 86 | 0.5 | 8 (19.8) | 2 (7.0) | 2 (15.1) | >16 (36.0) | 8 (19.8) | 1 (0) |
| 15-64 | 700 | 0.5 | 4 (15.4) | 2 (4.3) | 2 (13.0) | >16 (27.6) | 8 (18.3) | 1 (0.4) |
| >65 | 444 | 0.5 | 4 (15.8) | 2 (2.9) | 2 (12.6) | >16 (33.8) | 8 (21.2) | 1 (1.4) |
| Gender | ||||||||
| Male | 888 | 0.5 | 8 (19.8) | 2 (6.0) | 2 (16.0) | >16 (36.0) | 8 (24.8) | 1 (0.8) |
| Female | 651 | 0.5 | 8 (18.3) | 2 (6.9) | 2 (16.0) | >16 (31.2) | 8 (21.4) | 1 (0.3) |
| Location | ||||||||
| Inpatient | 696 | 0.5 | 8 (18.8) | 2 (5.2) | 2 (14.7) | >16 (33.0) | 8 (22.0) | 1 (0.1) |
| Outpatient | 847 | 0.5 | 8 (19.6) | 2 (7.4) | 4 (17.1) | >16 (34.8) | 8 (24.7) | 1 (0.9) |
a
MIC90s are expressed as micrograms per milliliter.
b
Breakpoints were not available to assess percent resistance for faropenem.